Valion Bio, Inc. VBIO

VBIO Company Overview

Tivic Health Systems, Inc. is a medical technology and consumer bioelectronic health company focused on developing non-invasive neuromodulation therapies. The company operates at the intersection of medical devices, bioelectronic medicine, and consumer health technology, with an emphasis on addressing chronic conditions through targeted electrical stimulation. Tivic Health’s products are designed to modulate neural pathways associated with inflammation and autonomic nervous system function.

The company’s primary revenue driver historically has been its FDA-cleared consumer device, ClearUP®, which is marketed for sinus pain and congestion relief. Tivic Health positions itself as a developer of clinically validated, non-pharmaceutical therapies that can be used at home. The company was founded in 2016 and went public in 2021 through an initial public offering, positioning itself to expand beyond consumer wellness into regulated therapeutic indications supported by clinical research.